TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6641089

Group type: EXPERIMENTAL
Intervention: Low-dose perhexiline during exercise training
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo during exercise training
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Low-dose perhexiline
Number of subjects: 22
Study: 31916303

Group type: EXPERIMENTAL
Intervention: NRT sampling plus standard care (SC)
Number of subjects: 1245

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 1245
Study: 28914700

Group type: EXPERIMENTAL
Intervention: 30 mg of IV ketorolac
Number of subjects: 40

Group type: COMPARATOR
Intervention: IV saline placebo
Number of subjects: 40
Study: 28185214

Group type: EXPERIMENTAL
Intervention: Lipoprotein apheresis (LA), regular LA treatment over 5 years
Number of subjects: 170
Study: 25275609

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prasugrel
Number of subjects: 0
Study: 23848384

Group type: EXPERIMENTAL
Intervention: Competition (Yes)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Intergroup competition (Yes)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Non-competitive work (No)
Number of subjects: 147
Study: 20853269

Group type: EXPERIMENTAL
Intervention: 1.25 mg intravitreal bevacizumab at the end of surgery
Number of subjects: 61

Group type: COMPARATOR
Intervention: Phacoemulsification with intraocular lens implantation alone (control group)
Number of subjects: 61
Study: 18195176

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (N=162), subcutaneously every 2 weeks for 1 year
Number of subjects: 319

Group type: COMPARATOR
Intervention: Placebo (N=157)
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa
Number of subjects: 319

Group type: COMPARATOR
Intervention: Darbepoetin alfa and Placebo
Number of subjects: 319
Study: 16368284

Group type: EXPERIMENTAL
Intervention: Oral anticoagulants (OAC) plus antiplatelet therapy
Number of subjects: 4889

Group type: EXPERIMENTAL
Intervention: Oral anticoagulants (OAC)
Number of subjects: 4889

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 4889

Group type: COMPARATOR
Intervention: Antiplatelet therapy alone
Number of subjects: 4889
Study: 12718496

Group type: EXPERIMENTAL
Intervention: Software program stimulating to take extra breaks
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Software program stimulating to perform exercises during extra breaks
Number of subjects: 268

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Intervention groups (both types)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 268
Study: 10704621

Group type: EXPERIMENTAL
Intervention: Simvastatin (0.01‐10 microM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medium (Control)
Number of subjects: 0
Study: 9092958

Group type: EXPERIMENTAL
Intervention: Topiramate (TPM) at target daily dosages of up to 9 mg/kg/day
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Adjunctive TPM therapy
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: TPM monotherapy substitution
Number of subjects: 18
Study: 8403580

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA), 7 injections over 6 weeks
Number of subjects: 57

Group type: COMPARATOR
Intervention: Mucopolysaccharide polysulfuric acid ester (MPA), 13 injections over 6 weeks
Number of subjects: 57
Study: 3782677

Group type: EXPERIMENTAL
Intervention: Red wine with low sulfur dioxide (SO2) and high amine
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Red wine with high sulfur dioxide (SO2) and high amine
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Red wine with low sulfur dioxide (SO2) and low amine
Number of subjects: 18
Study: 31674564

Group type: EXPERIMENTAL
Intervention: CS (Calibrate, and then Stitch) algorithm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SC (Stitch, and then Calibrate) algorithm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2D scans with step randomization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Regularization on low-order terms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Numerical simulations and experiments
Number of subjects: 0
Study: 29975728

Group type: EXPERIMENTAL
Intervention: Protein-reduced infant formula (1.89 g protein/100 kcal) with alpha-lactalbumin enriched whey and long-chain polyunsaturated fatty acids (LC-PUFA)
Number of subjects: 259

Group type: COMPARATOR
Intervention: Standard formula (2.2 g protein/100 kcal) without LC-PUFA
Number of subjects: 259

Group type: COMPARATOR
Intervention: Non-randomized breastfed infants (reference group)
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Metabolites measured at 4 months (Asn, Lys, Met, Phe, Trp, Tyr)
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Measured metabolites
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Early growth patterns
Number of subjects: 259
Study: 27957486

Group type: EXPERIMENTAL
Intervention: MTA (Mineral Trioxide Aggregate)
Number of subjects: 50

Group type: COMPARATOR
Intervention: IRM (Intermediate Restorative Material)
Number of subjects: 50
Study: 24615094

Group type: EXPERIMENTAL
Intervention: Remifentanil (target plasma concentration 3 ng/mL)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Propofol (target plasma concentration 2 μg/mL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (waiting for extubation)
Number of subjects: 60
Study: 22990628

Group type: EXPERIMENTAL
Intervention: Moderate intensity aerobic exercise (treadmill running)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Very high intensity aerobic exercise (treadmill running)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Very low intensity aerobic exercise (treadmill running)
Number of subjects: 0
Study: 20635523

Group type: EXPERIMENTAL
Intervention: Music only
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation only (PMR)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Music combined with progressive muscle relaxation
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control
Number of subjects: 32
Study: 18398095

Group type: EXPERIMENTAL
Intervention: High-dose ICE chemotherapy (ifosfamide, carboplatin, etoposide) with PBPC support
Number of subjects: 140

Group type: COMPARATOR
Intervention: Standard-dose ICE chemotherapy (ifosfamide, carboplatin, etoposide)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: High-dose ICE chemotherapy
Number of subjects: 140

Group type: COMPARATOR
Intervention: Standard-dose ICE chemotherapy
Number of subjects: 140
Study: 16872244

Group type: EXPERIMENTAL
Intervention: ezetimibe 10 mg/day
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: simvastatin 40 mg/day
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: ezetimibe 10 mg/day plus simvastatin 40 mg/day
Number of subjects: 72
Study: 14635608

Group type: EXPERIMENTAL
Intervention: Diuretics (in males)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Blockaders (in women)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Blockaders alpha (in women)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Antihypertensive treatment (phase 1)
Number of subjects: 70
Study: 11014911

Group type: EXPERIMENTAL
Intervention: Chlorzoin varnish
Number of subjects: 1240

Group type: EXPERIMENTAL
Intervention: Compliance with protocol (regular visits with dental auxiliaries)
Number of subjects: 1240

Group type: COMPARATOR
Intervention: Placebo varnish
Number of subjects: 1240

Group type: COMPARATOR
Intervention: Control group (observational)
Number of subjects: 1240
Study: 8615470

Group type: EXPERIMENTAL
Intervention: Preoperative combination treatment (radiation, intraluminal hyperthermia, and 5-fluorouracil suppositories)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Surgery after preoperative combination treatment
Number of subjects: 35

Group type: COMPARATOR
Intervention: Surgery without pretreatment (control group)
Number of subjects: 35
Study: 1731577

Group type: EXPERIMENTAL
Intervention: Warm bath (41 degrees C for 1/2 h, 2 1/2 h before sleep study)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (no warm bath)
Number of subjects: 7
Study: 3805328

Group type: EXPERIMENTAL
Intervention: Lithium treatment (0.8 mEq/liter for 1 week)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lithium treatment
Number of subjects: 12
Study: 29971998

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at Xialiao (BL 34) and Changqiang (GV 1), once a day.
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Auricular point sticking therapy at bilateral shenmen (TF4), pizhixia (AT4), jiaogan (AH6a) and gangmen (HX5), pressing 3-6 times every day, once 3-5 min.
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Combined group (EA + auricular point sticking therapy).
Number of subjects: 90
Study: 27801598

Group type: EXPERIMENTAL
Intervention: Eccentric-only (ECC)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Concentric-only (CONC)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Traditional concentric-eccentric (TRAD)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 34
Study: 25339836

Group type: EXPERIMENTAL
Intervention: Split-dose of 2-litre PEG-ELS
Number of subjects: 295

Group type: COMPARATOR
Intervention: Whole-dose of 2-litre PEG-ELS
Number of subjects: 295
Study: 20479755

Group type: EXPERIMENTAL
Intervention: Alcohol challenge in carriers of the minor 118G allele
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo challenge in carriers of the minor 118G allele
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alcohol challenge in h/mOPRM1‐118GG mice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alcohol challenge in h/mOPRM1‐118AA mice
Number of subjects: 0
Study: 16275527

Group type: EXPERIMENTAL
Intervention: Stress echocardiography
Number of subjects: 487
Study: 12140209

Group type: EXPERIMENTAL
Intervention: Hypotonic (150 mOsm/l) 0.4% hyaluronate eye drops
Number of subjects: 40

Group type: COMPARATOR
Intervention: Isotonic 0.4% hyaluronate eye drops
Number of subjects: 40
Study: 9656236

Group type: EXPERIMENTAL
Intervention: IL‐2, LAK adoptive immunotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 7654922

Group type: EXPERIMENTAL
Intervention: Self-medication
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Self-medication with antibiotics
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Self-medication with vitamins
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Self-medication for asthenia
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Previous medical prescription
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Common pharmacological groups
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Respiratory conditions
Number of subjects: 396
Study: 2647677

Group type: EXPERIMENTAL
Intervention: Modeling
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Modeling plus coping skills
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Any preparatory treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Attention placebo control
Number of subjects: 60
Study: 52766

Group type: EXPERIMENTAL
Intervention: High-carbohydrate/low-fat diet
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate/high-fat diet
Number of subjects: 8

Group type: COMPARATOR
Intervention: Normal balanced diet
Number of subjects: 8
Study: 12138261

Group type: EXPERIMENTAL
Intervention: Leucocytapheresis (LAP group)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Steroid pulse therapy (steroid pulse group)
Number of subjects: 32
Study: 31424972

Group type: EXPERIMENTAL
Intervention: Tailored DAA treatment based on baseline resistance findings, including prolonged treatment duration of NS5A-inhibitor and sofosbuvir (SOF) and/or addition of ribavirin (RBV) for patients with baseline Y93H.
Number of subjects: 208

Group type: COMPARATOR
Intervention: Standard DAA treatment for patients without baseline Y93H and all patients in the control group.
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Personalized treatment for patients with baseline Y93H in the intervention group.
Number of subjects: 208

Group type: COMPARATOR
Intervention: Standard treatment for patients with baseline Y93H in the control group.
Number of subjects: 208
Study: 29615318

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (50,000 IU every 25 days for 3 months)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 26878247

Group type: EXPERIMENTAL
Intervention: Dual-focus NBI (DF-NBI)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Conventional magnification NBI (CM-NBI)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Conventional magnification endoscope
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Dual-focus endoscope
Number of subjects: 93
Study: 24707819

Group type: EXPERIMENTAL
Intervention: Maternal presence during lullaby music exposure
Number of subjects: 22

Group type: COMPARATOR
Intervention: Ambient sound
Number of subjects: 22
Study: 22214529

Group type: EXPERIMENTAL
Intervention: Rehearsing enjoyable aspects of food immediately after eating
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no rehearsal of enjoyment)
Number of subjects: 0
Study: 20432339

Group type: EXPERIMENTAL
Intervention: MRI examination at 1.5 T
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: MRI examination at 7 T
Number of subjects: 25
Study: 18346959

Group type: EXPERIMENTAL
Intervention: Off pump coronary artery bypass (OPCAB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: On pump CABG (coronary artery bypass grafting)
Number of subjects: 0
Study: 15731561

Group type: EXPERIMENTAL
Intervention: Thermal balloon endometrial ablation
Number of subjects: 34

Group type: COMPARATOR
Intervention: Progestin therapy
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 34
Study: 12403606

Group type: EXPERIMENTAL
Intervention: Syllabic compression (fast time constant)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: High-frequency emphasis (SPIN setting)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Comfort-oriented pre-set program (AUTO)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Slow compression (AVC)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Intermediate compression (NORMAL)
Number of subjects: 38
Study: 9793946

Group type: EXPERIMENTAL
Intervention: Retrobulbar anesthesia (4 cc of a 50:50 mixture of 2% xylocaine and 0.75% bupivacaine with 150 units of hyaluronidase)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Peribulbar anesthesia (6 cc of a 50:50 mixture of 2% xylocaine and 0.75% bupivacaine with 150 units of hyaluronidase)
Number of subjects: 59
Study: 7659384

Group type: EXPERIMENTAL
Intervention: 111In-HIG
Number of subjects: 57

Group type: COMPARATOR
Intervention: Chest radiology
Number of subjects: 57
Study: 2565416

Group type: EXPERIMENTAL
Intervention: 10 mg bd tazifylline
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 1052162

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (200 mg intravenous infusion)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline solution (10 ml)
Number of subjects: 20
Study: 31669091

Group type: EXPERIMENTAL
Intervention: 1% iodine solution (group A)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: 2% iodine solution (group B)
Number of subjects: 77
Study: 31419427

Group type: EXPERIMENTAL
Intervention: Habitual physical exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-exercise
Number of subjects: 0
Study: 28481882

Group type: COMPARATOR
Intervention: 800 IU vitamin D3 daily for 6 months (Supplementation Study)
Number of subjects: 348

Group type: COMPARATOR
Intervention: 300 IU vitamin D3 daily in fortified milk for 7 weeks (Fortification Study)
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (both studies)
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (Fortification Study)
Number of subjects: 348
Study: 25297721

Group type: EXPERIMENTAL
Intervention: Topical clobetasol propionate cream (0.05%) applied at home
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Topical silver nitrate (99%) in the outpatient clinic
Number of subjects: 109

Group type: COMPARATOR
Intervention: Ethanol wipes (82%) at home
Number of subjects: 109
Study: 23107870

Group type: EXPERIMENTAL
Intervention: Carvedilol plus bepridil
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Candesartan plus bepridil
Number of subjects: 144

Group type: COMPARATOR
Intervention: Bepridil alone
Number of subjects: 144
Study: 21771340

Group type: EXPERIMENTAL
Intervention: 10-week worksite-based yoga program, delivered three times per week during lunch hour, led by an experienced yoga instructor.
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-treatment control group.
Number of subjects: 0
Study: 19786670

Group type: EXPERIMENTAL
Intervention: Trastuzumab plus anastrozole
Number of subjects: 207

Group type: COMPARATOR
Intervention: Anastrozole alone
Number of subjects: 207
Study: 16338019

Group type: EXPERIMENTAL
Intervention: Amantadine 100 mg twice daily for 48 weeks
Number of subjects: 209

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 209
Study: 14984391

Group type: EXPERIMENTAL
Intervention: Integrated treatment with cognitive‐behaviour therapy and coping training
Number of subjects: 63

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 63
Study: 11346245

Group type: EXPERIMENTAL
Intervention: Intravenous streptokinase therapy
Number of subjects: 32
Study: 9412633

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Carotid percutaneous transluminal angioplasty (PTA)
Number of subjects: 28
Study: 8434556

Group type: EXPERIMENTAL
Intervention: Probucol 0.5 g twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3628103

Group type: EXPERIMENTAL
Intervention: Viscoelastic insoles used in work shoes for five weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 100
Study: 29680079

Group type: EXPERIMENTAL
Intervention: Pelvic floor health workshop
Number of subjects: 50

Group type: COMPARATOR
Intervention: Routine prenatal care
Number of subjects: 50
Study: 27650295

Group type: EXPERIMENTAL
Intervention: Palonosetron plus TIVA (palonosetron 0.075 mg i.v.)
Number of subjects: 100

Group type: COMPARATOR
Intervention: TIVA (normal saline 1.5 ml i.v.)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Palonosetron plus TIVA
Number of subjects: 100

Group type: COMPARATOR
Intervention: TIVA
Number of subjects: 100
Study: 24010809

Group type: EXPERIMENTAL
Intervention: Anti-cellulite cosmetic applied for 6 weeks
Number of subjects: 20
Study: 22397815

Group type: EXPERIMENTAL
Intervention: 30 mg genistein daily for 3-6 weeks
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 47
Study: 20108098

Group type: EXPERIMENTAL
Intervention: Mediterranean diet with high proportion of phytate-rich foods
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mediterranean diet with low proportion of phytate-rich foods
Number of subjects: 0
Study: 18236302

Group type: EXPERIMENTAL
Intervention: Computer-tailored smoking cessation intervention based on the transtheoretical model; involved up to three individualized feedback letters.
Number of subjects: 611

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 611
Study: 16180527

Group type: EXPERIMENTAL
Intervention: Psychodynamic short-term psychotherapy (PSTP) - 25 sessions
Number of subjects: 20

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Psychodynamic short-term psychotherapy (PSTP)
Number of subjects: 20
Study: 12559286

Group type: EXPERIMENTAL
Intervention: Prophylactic breast irradiation (RT) with mostly single fraction (12 to 15 Gy) electrons
Number of subjects: 253

Group type: COMPARATOR
Intervention: No prophylactic breast irradiation (no-RT)
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Prophylactic breast irradiation (RT)
Number of subjects: 253
Study: 10595786

Group type: EXPERIMENTAL
Intervention: Beta-carotene (15 mg/day)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Lycopene (15 mg/day)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Lutein (15 mg/day)
Number of subjects: 69
Study: 8951132

Group type: EXPERIMENTAL
Intervention: Intracervical prostaglandin E2 (PGE2) gel (0.5 mg) followed by insertion of a 24-Foley catheter
Number of subjects: 78

Group type: COMPARATOR
Intervention: Intracervical prostaglandin E2 (PGE2) gel (two doses of 0.5 mg)
Number of subjects: 78
Study: 2021677

Group type: EXPERIMENTAL
Intervention: Alcohol ingestion (two dosage levels)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Monocular cues to motion in depth (dark condition)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Stereoscopic depth information (uniform condition)
Number of subjects: 20
Study: 6797661

Group type: EXPERIMENTAL
Intervention: Dobutamine (250-750 microgram/min)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Salbutamol (10-40 microgram/min)
Number of subjects: 9
Study: 30660574

Group type: EXPERIMENTAL
Intervention: Auditory-targeted cognitive training (TCT)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 46
Study: 27605038

Group type: EXPERIMENTAL
Intervention: Calorie restriction (7% weight loss over 3-6 months)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Exercise (7% weight loss over 3-6 months)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Combination of calorie restriction and exercise (7% weight loss over 3-6 months)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 52
Study: 27281448

Group type: EXPERIMENTAL
Intervention: Ambroxol Lozenges (AXL20) 20mg
Number of subjects: 2242

Group type: COMPARATOR
Intervention: Placebo Lozenges (PL)
Number of subjects: 2242
Study: 24407359

Group type: EXPERIMENTAL
Intervention: RIPer (PTCA combined with RIPer, consisting of three cycles of 5‐min inflation and 5‐min deflation of an upper‐arm blood‐pressure cuff initiated before reperfusion)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: RIPer+IPost (PTCA combined with RIPer and IPost, consisting of four cycles of 1‐min inflation and 1‐min deflation of the angioplasty balloon)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control (PTCA alone)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: RIPer and RIPer+IPost groups
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: RIPer+IPost and RIPer groups
Number of subjects: 151